These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33037840)

  • 1. Commentary on Jin et al. (2020): Expanding the impact of opioid agonist therapy for opioid use disorder-are there lessons from the HIV/AIDS response?
    Klimas J; Wood E; McCracken R
    Addiction; 2021 Feb; 116(2):429-430. PubMed ID: 33037840
    [No Abstract]   [Full Text] [Related]  

  • 2. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on Cousins et al. (2016): Accumulating evidence on risk of mortality on and off opioid substitution treatment.
    Hickman M; Macleod J; Degenhardt L
    Addiction; 2016 Jan; 111(1):83-4. PubMed ID: 26669528
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on Jin et al. (2020): Regulatory and allocative policies inform access to opioid agonist therapy.
    Priest KC
    Addiction; 2020 Dec; 115(12):2255-2256. PubMed ID: 32748483
    [No Abstract]   [Full Text] [Related]  

  • 5. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated opioid use disorder and HIV treatment: rationale, clinical guidelines for addiction treatment, and review of interactions of antiretroviral agents and opioid agonist therapies.
    Batkis MF; Treisman GJ; Angelino AF
    AIDS Patient Care STDS; 2010 Jan; 24(1):15-22. PubMed ID: 20095910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids and HIV Infection: From Pain Management to Addiction Treatment.
    Cunningham CO
    Top Antivir Med; 2018 Apr; 25(4):143-146. PubMed ID: 29689538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy.
    Soyka M; Hillemacher T
    Addiction; 2014 Jan; 109(1):88-9. PubMed ID: 24438113
    [No Abstract]   [Full Text] [Related]  

  • 9. Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction.
    Robinson SE
    CNS Drug Rev; 2002; 8(4):377-90. PubMed ID: 12481193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovations in efforts to expand treatment for opioid use disorder.
    Sigmon SC
    Prev Med; 2019 Nov; 128():105818. PubMed ID: 31445112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The medical management of opioid dependence in HIV primary care settings.
    Lum PJ; Tulsky JP
    Curr HIV/AIDS Rep; 2006 Nov; 3(4):195-204. PubMed ID: 17089480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine for opioid dependence.
    Milne M; Crouch BI; Caravati EM
    J Pain Palliat Care Pharmacother; 2009; 23(2):153-5. PubMed ID: 19492216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of Drugs Used to Treat Opioid Use Disorder.
    Aschenbrenner DS
    Am J Nurs; 2018 Aug; 118(8):25. PubMed ID: 30048283
    [No Abstract]   [Full Text] [Related]  

  • 14. Buprenorphine: a more accessible treatment for opioid dependence.
    Flassing J
    JAAPA; 2010 Sep; 23(9):40-3. PubMed ID: 20845653
    [No Abstract]   [Full Text] [Related]  

  • 15. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary on Freelemyer et al. (2014): medication-assisted treatment in Africa-need is growing but response remains tepid.
    Obot IS
    Addiction; 2014 Jan; 109(1):33-4. PubMed ID: 24438111
    [No Abstract]   [Full Text] [Related]  

  • 17. From methadone to buprenorphine: changes during a 10 year period within a national opioid maintenance treatment programme.
    Riksheim M; Gossop M; Clausen T
    J Subst Abuse Treat; 2014 Mar; 46(3):291-4. PubMed ID: 24210532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
    Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
    Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which substitution pharmacotherapy is most effective in treating opioid dependence?
    Gowing LR; Ali RL; White JM
    Med J Aust; 2002 May; 176(10):493-4. PubMed ID: 12065015
    [No Abstract]   [Full Text] [Related]  

  • 20. Treating opioid dependence--new data and new opportunities.
    O'Connor PG
    N Engl J Med; 2000 Nov; 343(18):1332-4. PubMed ID: 11058680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.